A10BJ05
E561028
A10BJ05 is the Anatomical Therapeutic Chemical (ATC) classification code assigned to dulaglutide, a GLP-1 receptor agonist used in the treatment of type 2 diabetes.
Statements (25)
| Predicate | Object |
|---|---|
| instanceOf |
ATC code
ⓘ
pharmacologic classification code ⓘ |
| anatomicalMainGroup | A10 (Drugs used in diabetes) ⓘ |
| assignedBy | World Health Organization Collaborating Centre for Drug Statistics Methodology NERFINISHED ⓘ |
| belongsTo | GLP-1 analogues ⓘ |
| chemicalSubstance | dulaglutide NERFINISHED ⓘ |
| classificationLevel | chemical substance level in ATC system ⓘ |
| codeFor | dulaglutide ⓘ |
| drugClass | GLP-1 receptor agonist ⓘ |
| fifthCharacterMeaning | J = GLP-1 analogues ⓘ |
| firstCharacterMeaning | A = Alimentary tract and metabolism ⓘ |
| fourthCharacterMeaning | B = Blood glucose lowering drugs, excl. insulins ⓘ |
| indicatesTherapeuticUse | treatment of type 2 diabetes mellitus ⓘ |
| partOfSystem | Anatomical Therapeutic Chemical classification system NERFINISHED ⓘ |
| pharmacologicalSubgroup | A10BJ (Glucagon-like peptide-1 (GLP-1) analogues) ⓘ |
| relatedDrug |
albiglutide
ⓘ
exenatide ⓘ liraglutide ⓘ lixisenatide NERFINISHED ⓘ semaglutide ⓘ |
| routeOfAdministration | subcutaneous use ⓘ |
| secondAndThirdCharactersMeaning | 10 = Drugs used in diabetes ⓘ |
| sixthAndSeventhCharactersMeaning | 05 = dulaglutide ⓘ |
| therapeuticSubgroup | A10B (Blood glucose lowering drugs, excl. insulins) ⓘ |
| usedIn | glycemic control in adults with type 2 diabetes ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.